{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:09:02Z","timestamp":1793261342036,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Single mutations in COL4A3\/COL4A4 genes have been described in patients with autosomal dominant Alport syndrome and thin basement membrane nephropathy, without a shared definition of these patients within the medical community. We aimed to better categorize this clinical entity by examining clinical manifestations, family history, pathological features and genetics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed patients with causative heterozygous COL4A3\/COL4A4 mutations referred to us between 1990 and 2019. Index cases were defined as children who were the first to be diagnosed in their families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 24 index cases and 29 affected relatives, belonging to 25 families with a heterozygous mutation in the COL4A3\/COL4A4 genes. During the follow-up, nine patients developed proteinuria [median age 15.7 years (range 5.6\u201333)], six at clinical diagnosis and four with progression toward chronic kidney disease (CKD) (three required kidney replacement therapy at 25, 45 and 53 years and one had CKD Stage 2 at 46 years). Extrarenal involvement was observed in 24.5% of patients. Hematuria was transmitted in consecutive generations, while CKD was reported in nonconsecutive generations of 11 families [median age 53 years (range 16\u201380)]. Seventeen patients (32%) underwent kidney biopsy: findings were consistent with Alport syndrome in 12 cases and with thin basement membrane nephropathy in 5 cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite the benign course for these patients described in the literature, a significant percentage is at risk for disease progression. Consequently, we suggest that the assessment of these patients must take into account family history, genetic analysis and pathologic findings. After comparison with the literature, our data suggest that a different definition for Alport syndrome must be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfab334","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T07:13:20Z","timestamp":1637306000000},"page":"2398-2407","source":"Crossref","is-referenced-by-count":12,"title":["Heterozygous\n                    <i>COL4A3\/COL4A4<\/i>\n                    mutations: the hidden part of the iceberg?"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-7439","authenticated-orcid":false,"given":"Antonio","family":"Mastrangelo","sequence":"first","affiliation":[{"name":"Pediatric Nephrology, Dialysis, and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Madeira","sequence":"additional","affiliation":[{"name":"University of Milan , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangela","family":"Castorina","sequence":"additional","affiliation":[{"name":"Casa di Cura Igea , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Giani","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, Dialysis, and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, Dialysis, and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan, Italy"},{"name":"Department of Clinical Sciences and Community Health, University of Milan , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"2022112304492809600_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","article-title":"A review of clinical characteristics and genetic backgrounds in Alport syndrome","volume":"23","author":"Nozu","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2022112304492809600_bib2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/ndt\/gfu254","article-title":"End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases","volume":"29","author":"Mallett","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2022112304492809600_bib3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10157-014-1077-8","article-title":"End-stage renal disease in Japanese children: a nationwide survey during 2006\u20132011","volume":"19","author":"Hattori","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"2022112304492809600_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome\u2014insights from basic and clinical research","volume":"9","author":"Kruegel","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2022112304492809600_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12688\/f1000research.9636.1","article-title":"Alport syndrome: facts and opinions","volume":"6","author":"Kashtan","year":"2017","journal-title":"F1000Res"},{"key":"2022112304492809600_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"key":"2022112304492809600_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","article-title":"Thin basement membrane nephropathy","volume":"64","author":"Savige","year":"2003","journal-title":"Kidney Int"},{"key":"2022112304492809600_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cge.12258","article-title":"Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases","volume":"86","author":"Fallerini","year":"2014","journal-title":"Clin Genet"},{"key":"2022112304492809600_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1681\/ASN.2005070737","article-title":"Thin basement membrane nephropathy","volume":"17","author":"Tryggvason","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492809600_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ndt\/gfn681","article-title":"Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome","volume":"24","author":"Marcocci","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2022112304492809600_bib11","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean community Alport syndrome concerted action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492809600_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492809600_bib13","first-page":"2946","article-title":"Molecular genetics of familial hematuric diseases","volume-title":"Nephrol Dial Transplant","author":"Deltas","year":"2013"},{"key":"2022112304492809600_bib14","first-page":"149","article-title":"Pathology of thin basement membrane nephropathy","volume-title":"Semin Nephrol","author":"Foster","year":"2005"},{"key":"2022112304492809600_bib15","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1093\/ndt\/gfm949","article-title":"Diagnostic accuracy of the 1007 protein\/creatinine ratio in urine samples to estimate 24 h proteinuria in patients with primary glomerulopathies: a longitudinal study","volume":"23","author":"Antunes","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2022112304492809600_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"2022112304492809600_bib17","first-page":"S1","article-title":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2022112304492809600_bib18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ekir.2018.08.002","article-title":"Should we diagnose autosomal dominant Alport syndrome when there is a pathogenic heterozygous COL4A3 or COL4A4 variant?","volume":"3","author":"Savige","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2022112304492809600_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-019-04241-7","article-title":"The importance of clinician, patient and researcher collaborations in Alport syndrome","volume":"35","author":"Rheault","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"2022112304492809600_bib20","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","article-title":"Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis","volume":"24","author":"Pierides","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2022112304492809600_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-011-1836-7","article-title":"Women and Alport syndrome","volume":"27","author":"Rheault","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2022112304492809600_bib22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","article-title":"Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling","volume":"17","author":"Gross","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2022112304492809600_bib23","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492809600_bib24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2215\/CJN.01000116","article-title":"Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome","volume":"11","author":"Kamiyoshi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492809600_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport syndrome: achieving early diagnosis and treatment","volume":"77","author":"Kashtan","year":"2021","journal-title":"Am J Kidney Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfab334\/42880765\/gfab334.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/12\/2398\/47202965\/gfab334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/12\/2398\/47202965\/gfab334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T23:49:47Z","timestamp":1669160987000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/12\/2398\/6433631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,11,23]]},"published-print":{"date-parts":[[2022,11,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfab334","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2021,11,23]]}}}